STOCK PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic decline today following the unexpected termination of its deal with pharmaceutical website giant Novo Nordisk. Investors interpreted negatively to the news, sending HIMS's stock price plummeting by over 10%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that